Is hyperthermic intraoperative peritoneal chemotherapy and systemic chemotherapy as effective as standard intraperitoneal chemotherapy: Time for a prospective trial?

Gynecologic Oncology

Volumn 122, Issue 2, 2011, Pages 207-208

  Edwards, Robert P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DOXORUBICIN;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; DRUG EFFICACY; EDITORIAL; HUMAN; HYPERTHERMIC INTRAOPERATIVE PERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; LENGTH OF STAY; MESOTHELIOMA; MULTIPLE CYCLE TREATMENT; OVARY CANCER; OVERALL SURVIVAL; PERITONEUM PSEUDOMYXOMA; POSTOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS;

EID: 79960469376     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.06.029     Document Type: Editorial

References (27)

1. W.J. Hoskins Epithelial ovarian carcinoma: principles of primary surgery Gynecol Oncol 55 3 Pt 2 1994 S91 S96
2. R.E. Bristow Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 5 2002 1248 1259 (Pubitemid 34177431)
3. R.E. Bristow Analysis of contemporary trends in access to high-volume ovarian cancer surgical care Ann Surg Oncol 16 12 2009 3422 3430
4. D.K. Armstrong, and M.F. Brady Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time J Clin Oncol 24 28 2006 4531 4533 (Pubitemid 46630946)
5. R.F. Ozols Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel Gynecol Oncol 103 1 2006 1 6 (Pubitemid 44374716)
6. D. Alberts Phase III study of intraperitoneal (IP) cisplatin (CDDP)/intravenous (IV) cyclophosphamide (CPA) s. IV CDDP/IV CPA in patients (PTS) with optimal disease stage III ovarian cancer Proceedings of ASCO 14 March 1995 273
7. M. Markman Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol 19 4 2001 1001 1007 (Pubitemid 32176274)
8. E.L. Trimble, and R.D. Alvarez Intraperitoneal chemotherapy and the NCI clinical announcement Gynecol Oncol 103 2 Suppl. 1 2006 S18 S19
9. R.W. Naumann, P. Sukumvanich, and R.P. Edwards Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer Gynecol Oncol 114 1 2009 37 41
10. J.L. Lesnock Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications Gynecol Oncol. 116 3 2010 345 350
11. J.S. Spratt Hyperthermic peritoneal perfusion system in canines Cancer Res 40 2 1980 253 255 (Pubitemid 10140144)
12. P.H. Sugarbaker, and D. Chang Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy Ann Surg Oncol 6 8 1999 727 731 (Pubitemid 30013648)
13. T.D. Yan Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database J Surg Oncol 96 2 2007 102 112 (Pubitemid 47264812)
14. C.W. Helm Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma Gynecol Oncol 105 1 2007 90 96 (Pubitemid 46441446)
15. N.J. Gusani Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol 15 3 2008 754 763
16. B. Barlogie, P.M. Corry, and B. Drewinko In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C Cancer Res 40 4 1980 1165 1168 (Pubitemid 10135826)
17. A.A. Mavanur Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma Int J Exp Pathol 91 4 2010 357 367
18. J. Michalakis Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro Ann Surg Oncol 14 3 2007 1220 1228
19. K. Wallner, and G.C. Li Adriamycin resistance, heat resistance and radiation response in Chinese hamster fibroblasts Int J Radiat Oncol Biol Phys 12 5 1986 829 833 (Pubitemid 16033483)
20. E.J. Hall, and L. Roizin-Towle Biological effects of heat Cancer Res 44 10 Suppl. 1984 4708s 4713s (Pubitemid 14000086)
21. M.A. Steller A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer Cancer Chemother Pharmacol 43 2 1999 106 114 (Pubitemid 29045027)
22. S.S. Lentz Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma Gynecol Oncol 106 1 2007 207 210 (Pubitemid 46898595)
23. J. Esquivel Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology Ann Surg Oncol 14 1 2007 128 133 (Pubitemid 44954279)
24. J. Esquivel Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination J Surg Oncol 98 4 2008 263 267
25. V.J. Verwaal Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 20 2003 3737 3743 (Pubitemid 46606227)
26. T.C. Chua Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results J Cancer Res Clin Oncol 135 12 2009 1637 1645
27. M. Markman Hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer: A critical need for an evidence-based evaluation Gynecol Oncol 113 1 2009 4 5